 Navin Fluorine International Ltd approves capex
Navin Fluorine International Ltd approves capex Purest gold, silver products in 10 minutes: MMTC-PAMP partners with Swiggy Instamart
Purest gold, silver products in 10 minutes: MMTC-PAMP partners with Swiggy Instamart Cosmo Plastech Expands Rigid Packaging Solutions for the Pharmaceutical Industry with PET Sheets
Cosmo Plastech Expands Rigid Packaging Solutions for the Pharmaceutical Industry with PET Sheets IPO Note - Lenskart Solutions Ltd - Reliance Securities
IPO Note - Lenskart Solutions Ltd - Reliance Securities IndiGo expands its Middle East footprint with new Bengaluru-Riyadh direct flights, starting 16 November 2025
IndiGo expands its Middle East footprint with new Bengaluru-Riyadh direct flights, starting 16 November 2025 
              Domestic equities recovered sharply from early losses today mainly on positive global cues and sharp rebound in IT, PSU Banks and Pharma. Stimulus bill in the USA continued to offer support to emerging markets including India. However, emerging risk pertaining to new coronavirus strain made investors to focus back to defensive sectors including IT, Pharma and FMCG. Notably, midcap and small cap stocks witnessed sharp rebound due to wider valuations gap compared to large cap peers.
While new imposed economic restrictions in various countries and threat of new coronavirus strain to other nations weigh on investors' sentiments, India still appears to be better placed given consistent reduction in new coronavirus cases and improvement in recovery rates. We believe domestic equities are likely to be volatile and trade in range bound in the near term and 3QFY21 corporate earnings are going to be crucial for the markets. As we believe broad based rally looks difficult hereon given rich valuations and a number of threats for earnings recovery, investors must focus on quality stocks with strong corporate governance and margin of safety with strong earnings potential.